The Global Varicella Live Vaccine market size was USD 3.25 billion in 2022 and it is forecasted to reach USD 5.29 billion by 2030. Varicella Live Vaccine Industry's Compound Annual Growth Rate will be 6.3% from 2023 to 2030.
